The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.
Elizabeth M RheaAric F LogsdonKim M HansenLindsey M WilliamsMay J ReedKristen K BaumannSarah J HoldenJacob RaberWilliam A BanksMichelle A EricksonPublished in: Nature neuroscience (2020)
It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome coronavirus 2 binds to cells via the S1 subunit of its spike protein. We show that intravenously injected radioiodinated S1 (I-S1) readily crossed the blood-brain barrier in male mice, was taken up by brain regions and entered the parenchymal brain space. I-S1 was also taken up by the lung, spleen, kidney and liver. Intranasally administered I-S1 also entered the brain, although at levels roughly ten times lower than after intravenous administration. APOE genotype and sex did not affect whole-brain I-S1 uptake but had variable effects on uptake by the olfactory bulb, liver, spleen and kidney. I-S1 uptake in the hippocampus and olfactory bulb was reduced by lipopolysaccharide-induced inflammation. Mechanistic studies indicated that I-S1 crosses the blood-brain barrier by adsorptive transcytosis and that murine angiotensin-converting enzyme 2 is involved in brain and lung uptake, but not in kidney, liver or spleen uptake.
Keyphrases
- respiratory syndrome coronavirus
- sars cov
- resting state
- coronavirus disease
- white matter
- lipopolysaccharide induced
- cerebral ischemia
- functional connectivity
- inflammatory response
- multiple sclerosis
- blood brain barrier
- adipose tissue
- induced apoptosis
- angiotensin ii
- high fat diet
- high dose
- signaling pathway
- amino acid
- cell proliferation
- subarachnoid hemorrhage
- small molecule
- protein kinase
- pi k akt
- mild cognitive impairment
- aqueous solution